EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Statins and reporting signals for amnesia: a pharmacovigilance analysis based on adverse event reporting database

Le Wang, Nan Yang, Zhiyong Ren

Frontiers in Pharmacology · 11.08.2026 · 17

DOI: 10.3389/fphar.2026.1858243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 11.08.2026. Verfasst von Le Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Provincial Mental Health Center, Taiyuan Psychiatric Hospital, Taiyuan, China. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to explore the disproportionality reporting signals of amnesia associated with different statins based on a spontaneous adverse event database, so as to provide preliminary pharmacovigilance evidence for subsequent clinical safety evaluation and further pharmacoepidemiological verification. Materials and methods This study employed pharmacovigilance analysis methods to monitor and analyze adverse event signals associated with seven commonly used statins. Additionally, subgroups were stratified by gender (male, female) and age (18, 45, and 65 years) to investigate the potential associations between statins and amnesia across different populations. Furthermore, a Weibull distribution analysis was used to assess the onset time of adverse events.

Results

A total of 56,401 statin-related adverse event reports were included, among which 1,108 valid cases were coded as amnesia. Significant positive pharmacovigilance signals were identified for atorvastatin (n = 326, ROR = 2.82, 95% CI: 2.53–3.15, P < 0.001), simvastatin (n = 600, ROR = 4.94, 95% CI: 4.55–5.35, P < 0.001), pravastatin (n = 68, ROR = 4.77, 95% CI: 3.76–6.06, P < 0.001), and lovastatin (n = 26, ROR = 6.96, 95% CI: 4.73–10.24, P < 0.001). Subgroup analyses stratified by gender and age further identified heterogeneous pharmacovigilance signals across distinct populations. Moreover, Weibull distribution analysis also revealed unique distribution patterns among different statin agents.

Conclusion

This study identified significant positive pharmacovigilance signals between certain statins and amnesia. The findings of this study provide preliminary disproportionality signals regarding statin-related amnesia, offering exploratory pharmacovigilance references for subsequent safety evaluation and further pharmacoepidemiological validation.

Schlagwörter

Stichwörter der Autor:innen

FAERS databaseamnesiaatorvastatinpharmacovigilance analysissimvastatinstatins

Autor:innen und Institutionen

  • Shanxi Provincial Mental Health Center, Taiyuan Psychiatric Hospital, Taiyuan, China.
  • Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.

Zitieren

APA

Wang, L., Yang, N., & Ren, Z. (2026). Statins and reporting signals for amnesia: a pharmacovigilance analysis based on adverse event reporting database. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1858243

Vancouver

Wang L, Yang N, Ren Z. Statins and reporting signals for amnesia: a pharmacovigilance analysis based on adverse event reporting database. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1858243

BibTeX
@article{Wang2026,
  author = {Wang, Le and Yang, Nan and Ren, Zhiyong},
  title = {Statins and reporting signals for amnesia: a pharmacovigilance analysis based on adverse event reporting database},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1858243}
}
Kostenlos starten →